Zoetis Inc. SEC filings ZTS
Zoetis Inc. has 1,004 filings in SEC EDGAR's recent list, going back to Feb 19, 2020. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 8, 2026 | — |
| DEF 14A | Proxy statement | Apr 8, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 9, 2025 | — |
| DEF 14A | Proxy statement | Apr 9, 2025 | May 21, 2025 |
| DEFA14A | Additional proxy material | May 8, 2024 | — |
| DEFA14A | Additional proxy material | May 6, 2024 | — |
| DEFA14A | Additional proxy material | Apr 10, 2024 | — |
| DEF 14A | Proxy statement | Apr 10, 2024 | May 22, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 27, 2024 | May 22, 2024 |
| DEFA14A | Additional proxy material | Apr 6, 2023 | — |
| DEF 14A | Proxy statement | Apr 6, 2023 | — |
| PRE 14A | Preliminary proxy statement | Mar 22, 2023 | — |
| DEFA14A | Additional proxy material | Apr 6, 2022 | — |
| DEF 14A | Proxy statement | Apr 6, 2022 | May 19, 2022 |
| PRE 14A | Preliminary proxy statement | Mar 18, 2022 | May 19, 2022 |
| DEFA14A | Additional proxy material | Apr 6, 2021 | — |
| DEF 14A | Proxy statement | Apr 6, 2021 | May 20, 2021 |
| DEFA14A | Additional proxy material | Apr 6, 2020 | — |
| DEF 14A | Proxy statement | Apr 6, 2020 | May 20, 2020 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ZTS (NYSE)
- Fiscal year ends
- December 31
- Headquarters
- Parsippany, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1555280
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.